ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00608803
Recruitment Status : Completed
First Posted : February 6, 2008
Last Update Posted : September 17, 2009
Sponsor:
Information provided by:
Ziopharm

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2009
  Actual Study Completion Date : January 2009